Join the club for FREE to access the whole archive and other member benefits.

Synpromics

Company that develops and commercializes synthetic promoters to control gene expressions and regulations

Synpromics is the leader in gene control, improving human health by enabling safer, more effective cell and gene medicines through proprietary genomics, bioinformatics and intelligent data driven design. Synpromics enables unprecedented control of gene expression through its ability to custom design synthetic cell-type, or condition, specific promoters. We achieve this by using proprietary technology and cutting edge techniques including sophisticated bioinformatics and screening approaches.

Purchased by AskBio on 13-Aug-2019

Visit website: https://www.synpromics.com/

 synpromics-ltd

 synpromics

Details last updated 03-Oct-2019

Mentioned in this Resource

Asklepios BioPharmaceutical (AskBio)

Clinical-stage AAV gene therapy company for patients with rare diseases and other disorders

Synpromics News

Targeting Senescent Cells with Synthetic Biology

Lifespan.io (LEAF) - 09-Dec-2016

CellAge is going to develop synthetic promoters which are specific to senescent cells, as promote...

Read more...
Topics mentioned on this page:
Gene Therapy, Stem Cells